CapitolMarkets
Conflict surface

Committee conflicts

Trades and disclosed holdings where the politician sits on a committee whose jurisdiction overlaps the security's sector. Not an accusation of wrongdoing — STOCK Act trades are legal — but a structural conflict-of-interest signal worth noting.

Trade flags
283
single-trade conflicts
Politicians flagged
28
at least one conflict
Position holdings
65
flagged annual-filing rows
Top sector
Pharmaceutical
283 flagged trades
Filter by sector
Position-level conflicts

Who owns what they regulate

Disclosed annual holdings in sectors the politician's committee or agency oversees, sorted by upper-bound disclosed value. Click any row to expand the per-position detail and source filing.

Total disclosed band
$532.5K – $2M
From House Form A · Senate EFD · OGE 278e
  • Ashley Moody
    Ashley Moody
    RSenate
    Pharmaceutical
    Positions
    9
    Total band
    $135K – $375K
    See per-position detail
    Crispr Therapeutics Ag
    CRSP
    Pharmaceutical
    Senator on 5 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $50K – $100K
    Biomarin Pharmaceutical
    BMRN
    Pharmaceutical
    Senator on 5 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $50K – $100K
    Crispr Therapeutics Ag
    CRSP
    Pharmaceutical
    Senator on 5 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Arcturus Therapeutics Holdings
    ARCT
    Pharmaceutical
    Senator on 5 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Solid Biosciences
    SLDB
    Pharmaceutical
    Senator on 5 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    ADC Therapeutics Sa
    ADCT
    Pharmaceutical
    Senator on 5 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Stoke Therapeutics
    STOK
    Pharmaceutical
    Senator on 5 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Pliant Therapeutics
    PLRX
    Pharmaceutical
    Senator on 5 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Heron Therapeutics, Inc.
    HRTX
    Pharmaceutical
    Senator on 5 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Shelley Moore Capito
    Shelley Moore Capito
    RSenate
    Pharmaceutical
    Positions
    12
    Total band
    $68K – $320K
    See per-position detail
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Eli Lilly
    LLY
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Amgen
    AMGN
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Amgen
    AMGN
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    R
    RHHBY
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Merck
    MRK
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Zoetis
    ZTS
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Pfizer
    PFE
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Novartis Ag
    NVS
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Gilead Sciences
    GILD
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Tommy Tuberville
    Tommy Tuberville
    RSenate
    Pharmaceutical
    Positions
    6
    Total band
    $76K – $265K
    See per-position detail
    Pfizer
    PFE
    Pharmaceutical
    Senator on 5 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Eli Lilly
    LLY
    Pharmaceutical
    Senator on 5 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    AbbVie
    ABBV
    Pharmaceutical
    Senator on 5 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Amgen
    AMGN
    Pharmaceutical
    Senator on 5 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Pfizer
    PFE
    Pharmaceutical
    Senator on 5 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Bristol-Myers Squibb
    BMY
    Pharmaceutical
    Senator on 5 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Pete Sessions
    Pete Sessions
    RHouse
    Pharmaceutical
    Positions
    5
    Total band
    $61K – $215K
    See per-position detail
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Representative on 4 committees including Committee on Financial Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Representative on 4 committees including Committee on Financial Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Representative on 4 committees including Committee on Financial Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    AbbVie
    ABBV
    Pharmaceutical
    Representative on 4 committees including Committee on Financial Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    AbbVie
    ABBV
    Pharmaceutical
    Representative on 4 committees including Committee on Financial Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Susan M. Collins
    Susan M. Collins
    RSenate
    Pharmaceutical
    Positions
    5
    Total band
    $61K – $215K
    See per-position detail
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Merck
    MRK
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Merck
    MRK
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    I
    IBB
    Pharmaceutical
    Chair, Committee on Appropriations on 3 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Roger F. Wicker
    Roger F. Wicker
    RSenate
    Pharmaceutical
    Positions
    4
    Total band
    $32K – $130K
    See per-position detail
    Merck
    MRK
    Pharmaceutical
    Chair, Committee on Armed Services on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Merck
    MRK
    Pharmaceutical
    Chair, Committee on Armed Services on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Merck
    MRK
    Pharmaceutical
    Chair, Committee on Armed Services on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Merck
    MRK
    Pharmaceutical
    Chair, Committee on Armed Services on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • John Boozman
    John Boozman
    RSenate
    Pharmaceutical
    Positions
    7
    Total band
    $7K – $105K
    See per-position detail
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Chair, Committee on Agriculture, Nutrition, and Forestry on 6 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    AbbVie
    ABBV
    Pharmaceutical
    Chair, Committee on Agriculture, Nutrition, and Forestry on 6 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    AbbVie
    ABBV
    Pharmaceutical
    Chair, Committee on Agriculture, Nutrition, and Forestry on 6 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Eli Lilly
    LLY
    Pharmaceutical
    Chair, Committee on Agriculture, Nutrition, and Forestry on 6 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Chair, Committee on Agriculture, Nutrition, and Forestry on 6 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Gilead Sciences
    GILD
    Pharmaceutical
    Chair, Committee on Agriculture, Nutrition, and Forestry on 6 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Pfizer
    PFE
    Pharmaceutical
    Chair, Committee on Agriculture, Nutrition, and Forestry on 6 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • David Kustoff
    David Kustoff
    RHouse
    Pharmaceutical
    Positions
    1
    Total band
    $50K – $100K
    See per-position detail
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Representative on 3 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $50K – $100K
  • Bill Hagerty
    Bill Hagerty
    RSenate
    Pharmaceutical
    Positions
    1
    Total band
    $15K – $50K
    See per-position detail
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Senator on 7 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
  • Mike Kelly
    Mike Kelly
    RHouse
    Pharmaceutical
    Positions
    1
    Total band
    $15K – $50K
    See per-position detail
    Bristol-Myers Squibb
    BMY
    Pharmaceutical
    Chair, Committee on Ways and Means on 3 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
  • Richard McCormick
    Richard McCormick
    RHouse
    Pharmaceutical
    Positions
    3
    Total band
    $3K – $45K
    See per-position detail
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Chair, Committee on Oversight and Government Reform on 6 committees including Committee on Oversight and Government Reform holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    R
    RHHBY
    Pharmaceutical
    Chair, Committee on Oversight and Government Reform on 6 committees including Committee on Oversight and Government Reform holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    R
    RHHBY
    Pharmaceutical
    Chair, Committee on Oversight and Government Reform on 6 committees including Committee on Oversight and Government Reform holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Blake D. Moore
    Blake D. Moore
    RHouse
    Pharmaceutical
    Positions
    2
    Total band
    $2K – $30K
    See per-position detail
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Representative on 4 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Representative on 4 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Dan Newhouse
    Dan Newhouse
    RHouse
    Pharmaceutical
    Positions
    2
    Total band
    $2K – $30K
    See per-position detail
    Eli Lilly
    LLY
    Pharmaceutical
    Chair, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Zoetis
    ZTS
    Pharmaceutical
    Chair, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Rand Paul
    Rand Paul
    RSenate
    Pharmaceutical
    Positions
    1
    Total band
    $1K – $15K
    See per-position detail
    Gilead Sciences
    GILD
    Pharmaceutical
    Chair, Committee on Foreign Relations on 7 committees including Committee on Foreign Relations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Laurel M. Lee
    Laurel M. Lee
    RHouse
    Pharmaceutical
    Positions
    1
    Total band
    $1K – $15K
    See per-position detail
    Pfizer
    PFE
    Pharmaceutical
    Representative on 5 committees including Energy holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
Trade-level conflicts

Every flagged trade

Individual buy/sell disclosures from the STOCK Act periodic transaction reports, flagged where the trade's sector aligns with the politician's committee jurisdiction at the time it was filed.

  • Filed Apr 13, 2026
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    75trades in committee-overseen sectors
  • Filed Apr 7, 2026
    sold
    Johnson & Johnson
    JNJ
    CommitteeInvestigations and Oversight
    SectorPharmaceutical
    Pattern
    40trades in committee-overseen sectors
  • Filed Apr 7, 2026
    sold
    Johnson & Johnson
    JNJ
    CommitteeInvestigations and Oversight
    SectorPharmaceutical
    Pattern
    40trades in committee-overseen sectors
  • Filed Apr 3, 2026
    Kevin Hern
    $8K
    sold
    Exact Sciences
    EXAS
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    85trades in committee-overseen sectors
  • Filed Mar 25, 2026
    Susan M. Collins
    $32.5K
    bought
    PfizerBond
    PFE
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    6trades in committee-overseen sectors
  • Filed Feb 19, 2026
    Thomas H. Kean Jr.
    $32.5K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    75trades in committee-overseen sectors
  • Filed Dec 19, 2025
    Thomas H. Kean Jr.
    $32.5K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    75trades in committee-overseen sectors
  • Filed Dec 9, 2025
    bought
    Johnson & Johnson
    JNJ
    CommitteeInvestigations and Oversight
    SectorPharmaceutical
    Pattern
    40trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    AstraZeneca
    AZN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    United Therapeutics
    UTHR
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    AbbVie
    ABBV
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    Repligen
    RGEN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    Novartis Ag
    NVS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    Johnson & Johnson
    JNJ
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    Novo Nordisk
    NVO
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    GSK PLC
    GSK
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    bought
    United Therapeutics
    UTHR
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    United Therapeutics
    UTHR
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    bought
    Johnson & Johnson
    JNJ
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    Novartis Ag
    NVS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    bought
    Repligen
    RGEN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    GSK PLC
    GSK
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    AbbVie
    ABBV
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    Novo Nordisk
    NVO
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    bought
    Novo Nordisk
    NVO
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    bought
    AbbVie
    ABBV
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    bought
    Novartis Ag
    NVS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    Repligen
    RGEN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    bought
    AstraZeneca
    AZN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    bought
    GSK PLC
    GSK
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    Johnson & Johnson
    JNJ
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 21, 2025
    sold
    AstraZeneca
    AZN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Nov 4, 2025
    bought
    Eli Lilly
    LLY
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    159trades in committee-overseen sectors
  • Filed Oct 22, 2025
    sold
    Amgen
    AMGN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Oct 22, 2025
    sold
    Novartis Ag
    NVS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Oct 22, 2025
    bought
    Novartis Ag
    NVS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Oct 22, 2025
    sold
    Sanofi
    SNY
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Oct 22, 2025
    bought
    Novo Nordisk
    NVO
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Oct 5, 2025
    Sheri Biggs
    $32.5K
    sold
    Merck
    MRK
    CommitteeResearch and Technology
    SectorPharmaceutical
    Pattern
    29trades in committee-overseen sectors
  • Filed Oct 5, 2025
    Sheri Biggs
    $32.5K
    sold
    Johnson & Johnson
    JNJ
    CommitteeResearch and Technology
    SectorPharmaceutical
    Pattern
    29trades in committee-overseen sectors
  • Filed Sep 17, 2025
    bought
    Johnson & Johnson
    JNJ
    CommitteeInvestigations and Oversight
    SectorPharmaceutical
    Pattern
    40trades in committee-overseen sectors
  • Filed Sep 12, 2025
    bought
    GSK PLC
    GSK
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Sep 12, 2025
    sold
    Novo Nordisk
    NVO
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Sep 12, 2025
    sold
    Merck
    MRK
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Sep 12, 2025
    sold
    Zoetis
    ZTS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Sep 12, 2025
    bought
    Sanofi
    SNY
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Sep 12, 2025
    bought
    Johnson & Johnson
    JNJ
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Sep 12, 2025
    sold
    Pfizer
    PFE
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 20, 2025
    Thomas H. Kean Jr.
    $32.5K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    75trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    AstraZeneca
    AZN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    AbbVie
    ABBV
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Novartis Ag
    NVS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Repligen
    RGEN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    AbbVie
    ABBV
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Sanofi
    SNY
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Zoetis
    ZTS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Eli Lilly
    LLY
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Pfizer
    PFE
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Novo Nordisk
    NVO
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Eli Lilly
    LLY
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Johnson & Johnson
    JNJ
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Merck
    MRK
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    GSK PLC
    GSK
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Amgen
    AMGN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Sanofi
    SNY
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Repligen
    RGEN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    GSK PLC
    GSK
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    AstraZeneca
    AZN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    AbbVie
    ABBV
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Neurocrine Biosciences
    NBIX
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Johnson & Johnson
    JNJ
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Novartis Ag
    NVS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Novartis Ag
    NVS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    United Therapeutics
    UTHR
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Repligen
    RGEN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Neurocrine Biosciences
    NBIX
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Vertex Pharmaceuticals
    VRTX
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Novartis Ag
    NVS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Vertex Pharmaceuticals
    VRTX
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Eli Lilly
    LLY
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Novo Nordisk
    NVO
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Novartis Ag
    NVS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    AstraZeneca
    AZN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    sold
    Zoetis
    ZTS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Vertex Pharmaceuticals
    VRTX
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Zoetis
    ZTS
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 13, 2025
    bought
    Eli Lilly
    LLY
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    525trades in committee-overseen sectors
  • Filed Aug 9, 2025
    Laurel M. Lee
    $75K
    bought
    Tuhura Biosciences, Inc.
    HURA
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    13trades in committee-overseen sectors
  • Filed Jul 9, 2025
    Cliff Bentz
    $8K
    bought
    Amgen
    AMGN
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    3trades in committee-overseen sectors
  • Filed Jul 3, 2025
    Virginia Foxx
    $8K
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    47trades in committee-overseen sectors
  • Filed Jun 22, 2025
    Laurel M. Lee
    $8K
    sold
    Novo Nordisk
    NVO
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    13trades in committee-overseen sectors
  • Filed Jun 9, 2025
    bought
    Biogen
    BIIB
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Jun 9, 2025
    bought
    Regeneron Pharmaceuticals
    REGN
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Jun 9, 2025
    bought
    AbbVie
    ABBV
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed May 31, 2025
    sold
    Incyte
    INCY
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed May 31, 2025
    bought
    Zoetis
    ZTS
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed May 31, 2025
    sold
    Merck
    MRK
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed May 16, 2025
    Dan Newhouse
    $8K
    sold
    Eli Lilly
    LLY
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    22trades in committee-overseen sectors
  • Filed May 15, 2025
    Tommy Tuberville
    $32.5K
    sold
    Amgen
    AMGN
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed May 15, 2025
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed May 15, 2025
    Tommy Tuberville
    $32.5K
    sold
    Eli Lilly
    LLY
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed May 8, 2025
    sold
    Biogen
    BIIB
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed May 8, 2025
    sold
    Moderna
    MRNA
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed May 8, 2025
    sold
    Amgen
    AMGN
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed May 8, 2025
    bought
    Merck
    MRK
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed May 8, 2025
    sold
    Regeneron Pharmaceuticals
    REGN
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed May 8, 2025
    sold
    AbbVie
    ABBV
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Apr 28, 2025
    sold
    Zoetis
    ZTS
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Apr 28, 2025
    sold
    Johnson & Johnson
    JNJ
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Apr 28, 2025
    sold
    Pfizer
    PFE
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Apr 28, 2025
    sold
    Eli Lilly
    LLY
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Apr 11, 2025
    bought
    Gilead Sciences
    GILD
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    35trades in committee-overseen sectors
  • Filed Apr 11, 2025
    sold
    Pfizer
    PFE
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    35trades in committee-overseen sectors
  • Filed Mar 27, 2025
    bought
    AbbVie
    ABBV
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Mar 27, 2025
    bought
    Biogen
    BIIB
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Mar 27, 2025
    sold
    Regeneron Pharmaceuticals
    REGN
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Mar 27, 2025
    bought
    Moderna
    MRNA
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Mar 27, 2025
    sold
    Merck
    MRK
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Mar 27, 2025
    sold
    Zoetis
    ZTS
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    225trades in committee-overseen sectors
  • Filed Jan 15, 2025
    Kevin Hern
    $175K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    85trades in committee-overseen sectors
  • Filed Jan 7, 2025
    Laurel M. Lee
    $8K
    bought
    Tuhura Biosciences, Inc.
    HURA
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    13trades in committee-overseen sectors
  • Filed Jan 6, 2025
    Virginia Foxx
    $8K
    bought
    Amgen
    AMGN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    47trades in committee-overseen sectors
  • Filed Jan 6, 2025
    Virginia Foxx
    $8K
    bought
    Bristol-Myers Squibb
    BMY
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    47trades in committee-overseen sectors
  • Filed Jan 6, 2025
    Virginia Foxx
    $8K
    bought
    AbbVie
    ABBV
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    47trades in committee-overseen sectors
  • Filed Jan 6, 2025
    Virginia Foxx
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    47trades in committee-overseen sectors
  • Filed Nov 21, 2024
    Laurel M. Lee
    $150K
    exchanged
    Pfizer
    PFE
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    13trades in committee-overseen sectors
  • Filed Nov 21, 2024
    Laurel M. Lee
    $175K
    exchanged
    Tuhura Biosciences, Inc.
    HURA
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    13trades in committee-overseen sectors
  • Filed Nov 15, 2024
    Tommy Tuberville
    $32.5K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Sep 6, 2024
    John James
    $8K
    sold
    Sanofi
    SNY
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Sep 6, 2024
    John James
    $8K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Sep 6, 2024
    John James
    $8K
    sold
    AbbVie
    ABBV
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Sep 6, 2024
    John James
    $8K
    sold
    Novo Nordisk
    NVO
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Sep 6, 2024
    John James
    $8K
    sold
    Merck
    MRK
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Sep 2, 2024
    John James
    $8K
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Sep 2, 2024
    John James
    $8K
    bought
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Sep 2, 2024
    John James
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Sep 2, 2024
    John James
    $8K
    bought
    Merck
    MRK
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Sep 2, 2024
    John James
    $8K
    bought
    Novo Nordisk
    NVO
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Sep 2, 2024
    John James
    $8K
    bought
    Sanofi
    SNY
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Sep 2, 2024
    John James
    $8K
    bought
    AbbVie
    ABBV
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    195trades in committee-overseen sectors
  • Filed Aug 8, 2024
    Rick W. Allen
    $32.5K
    sold
    Johnson & Johnson
    JNJ
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    168trades in committee-overseen sectors
  • Filed Jul 15, 2024
    Kevin Hern
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    85trades in committee-overseen sectors
  • Filed Jul 10, 2024
    Rick W. Allen
    $32.5K
    sold
    Johnson & Johnson
    JNJ
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    168trades in committee-overseen sectors
  • Filed Jun 14, 2024
    bought
    Gilead SciencesOption
    GILD
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Jun 14, 2024
    bought
    Gilead SciencesOption
    GILD
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Jun 14, 2024
    bought
    Gilead SciencesOption
    GILD
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Jun 14, 2024
    bought
    S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024Option
    XBI
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Jun 14, 2024
    bought
    S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024Option
    XBI
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Jun 14, 2024
    sold
    Gilead Sciences
    GILD
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Jun 14, 2024
    sold
    Vertex Pharmaceuticals
    VRTX
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Jun 14, 2024
    Tommy Tuberville
    $32.5K
    sold
    Pfizer
    PFE
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed May 15, 2024
    bought
    Gilead Sciences
    GILD
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed May 15, 2024
    sold
    Regeneron Pharmaceuticals
    REGN
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed May 15, 2024
    Tommy Tuberville
    $32.5K
    sold
    Eli Lilly
    LLY
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed May 15, 2024
    bought
    Bristol-Myers SquibbOption
    BMY
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed May 15, 2024
    bought
    AbbVieOption
    ABBV
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed May 15, 2024
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed May 15, 2024
    sold
    Gilead SciencesOption
    GILD
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Apr 25, 2024
    Dan Newhouse
    $8K
    sold
    Eli Lilly
    LLY
    CommitteeConservation, Research, and Biotechnology
    SectorPharmaceutical
    Pattern
    22trades in committee-overseen sectors
  • Filed Apr 12, 2024
    Kevin Hern
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    85trades in committee-overseen sectors
  • Filed Mar 15, 2024
    bought
    Zoetis
    ZTS
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    159trades in committee-overseen sectors
  • Filed Mar 15, 2024
    bought
    Pfizer
    PFE
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Feb 14, 2024
    sold
    AbbVie
    ABBV
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Feb 14, 2024
    Tommy Tuberville
    $32.5K
    sold
    Novo Nordisk
    NVO
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Feb 14, 2024
    Tommy Tuberville
    $32.5K
    sold
    Amgen
    AMGN
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Feb 14, 2024
    Tommy Tuberville
    $32.5K
    sold
    Eli Lilly
    LLY
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Feb 14, 2024
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Feb 11, 2024
    Kevin Hern
    $8K
    sold
    Exact Sciences
    EXAS
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    85trades in committee-overseen sectors
  • Filed Jan 24, 2024
    Blake D. Moore
    $22.5K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    115trades in committee-overseen sectors
  • Filed Jan 24, 2024
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    115trades in committee-overseen sectors
  • Filed Jan 17, 2024
    Jerry Moran
    $8K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    60trades in committee-overseen sectors
  • Filed Jan 17, 2024
    Jerry Moran
    $8K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    60trades in committee-overseen sectors
  • Filed Jan 17, 2024
    Jerry Moran
    $8K
    sold
    Pfizer
    PFE
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    60trades in committee-overseen sectors
  • Filed Jan 12, 2024
    sold
    Pfizer
    PFE
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    159trades in committee-overseen sectors
  • Filed Dec 15, 2023
    sold
    AbbVieOption
    ABBV
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Dec 15, 2023
    sold
    Bristol-Myers SquibbOption
    BMY
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Nov 16, 2023
    bought
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Nov 16, 2023
    bought
    AbbVie
    ABBV
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Nov 16, 2023
    sold
    Merck
    MRK
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Nov 16, 2023
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Nov 16, 2023
    sold
    GSK PLC
    GSK
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Oct 13, 2023
    Kevin Hern
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    85trades in committee-overseen sectors
  • Filed Oct 13, 2023
    sold
    Eli Lilly
    LLY
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Oct 4, 2023
    John R. Curtis
    $8K
    bought
    Eli Lilly
    LLY
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    122trades in committee-overseen sectors
  • Filed Oct 4, 2023
    John R. Curtis
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    122trades in committee-overseen sectors
  • Filed Sep 22, 2023
    Dan Sullivan
    $8K
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    114trades in committee-overseen sectors
  • Filed Sep 22, 2023
    Dan Sullivan
    $8K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    114trades in committee-overseen sectors
  • Filed Sep 22, 2023
    Dan Sullivan
    $8K
    sold
    Zoetis
    ZTS
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    114trades in committee-overseen sectors
  • Filed Sep 18, 2023
    Dan Sullivan
    $8K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    114trades in committee-overseen sectors
  • Filed Sep 18, 2023
    Dan Sullivan
    $8K
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    114trades in committee-overseen sectors
  • Filed Sep 18, 2023
    Dan Sullivan
    $8K
    sold
    Zoetis
    ZTS
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    114trades in committee-overseen sectors
  • Filed Sep 5, 2023
    Virginia Foxx
    $32.5K
    sold
    Takeda Pharmaceutical Co. Ltd.
    TAK
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    47trades in committee-overseen sectors
  • Filed Aug 14, 2023
    bought
    Pfizer
    PFE
    CommitteeCommittee on Health, Education, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    459trades in committee-overseen sectors
  • Filed Aug 10, 2023
    Rick W. Allen
    $32.5K
    sold
    Pfizer
    PFE
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    168trades in committee-overseen sectors
  • Filed Aug 10, 2023
    Rick W. Allen
    $32.5K
    bought
    Amgen
    AMGN
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    168trades in committee-overseen sectors
  • Filed Aug 10, 2023
    Rick W. Allen
    $32.5K
    bought
    Johnson & Johnson
    JNJ
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    168trades in committee-overseen sectors
  • Filed Aug 10, 2023
    Rick W. Allen
    $32.5K
    sold
    Merck
    MRK
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    168trades in committee-overseen sectors
  • Filed Aug 10, 2023
    Rick W. Allen
    $32.5K
    bought
    AbbVie
    ABBV
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    168trades in committee-overseen sectors
  • Filed Aug 10, 2023
    Rick W. Allen
    $32.5K
    bought
    Merck
    MRK
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    168trades in committee-overseen sectors
  • Filed Aug 10, 2023
    Rick W. Allen
    $32.5K
    bought
    Pfizer
    PFE
    CommitteeHealth, Employment, Labor, and Pensions
    SectorPharmaceutical
    Pattern
    168trades in committee-overseen sectors

Conflict flags are computed automatically by matching each politician's active committee assignments against the GICS sector of every ticker they trade or hold. A flag is a structural signal, not an accusation: STOCK Act trades are legal and Annual financial disclosures are required by law. Read the full methodology.